ZNF414
gene geneOn this page
Also known as MGC15716Zfp414
Summary
ZNF414 (zinc finger protein 414, HGNC:20630) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 414 (Q96IQ9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 84330 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_001146175
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20630 |
| Approved symbol | ZNF414 |
| Name | zinc finger protein 414 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC15716, Zfp414 |
| Ensembl gene | ENSG00000133250 |
| Ensembl biotype | protein_coding |
| OMIM | 620980 |
| Entrez | 84330 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 5 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000255616, ENST00000393927, ENST00000593661, ENST00000594748, ENST00000595348, ENST00000596772, ENST00000599379, ENST00000600906, ENST00000602128
RefSeq mRNA: 2 — MANE Select: NM_001146175
NM_001146175, NM_032370
CCDS: CCDS12205, CCDS54211
Canonical transcript exons
ENST00000393927 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000910009 | 8511617 | 8511960 |
| ENSE00000910012 | 8513029 | 8513341 |
| ENSE00001516941 | 8510851 | 8511024 |
| ENSE00001516942 | 8511486 | 8511536 |
| ENSE00001658196 | 8509678 | 8510764 |
| ENSE00003095870 | 8514044 | 8514167 |
| ENSE00003508437 | 8512604 | 8512711 |
| ENSE00003546179 | 8512387 | 8512492 |
Expression profiles
Bgee: expression breadth ubiquitous, 158 present calls, max score 91.69.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.1324 / max 178.4977, expressed in 1802 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178958 | 14.1256 | 1794 |
| 178956 | 1.4043 | 877 |
| 178957 | 0.4162 | 173 |
| 178954 | 0.1491 | 62 |
| 178955 | 0.0371 | 15 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 91.69 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 91.53 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.78 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.70 | gold quality |
| body of uterus | UBERON:0009853 | 90.66 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.30 | gold quality |
| apex of heart | UBERON:0002098 | 90.26 | gold quality |
| left ovary | UBERON:0002119 | 90.25 | gold quality |
| ectocervix | UBERON:0012249 | 90.23 | gold quality |
| endocervix | UBERON:0000458 | 90.13 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.85 | gold quality |
| ventricular zone | UBERON:0003053 | 89.61 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 89.54 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.53 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 89.48 | gold quality |
| left uterine tube | UBERON:0001303 | 89.26 | gold quality |
| right uterine tube | UBERON:0001302 | 89.12 | gold quality |
| left adrenal gland | UBERON:0001234 | 89.06 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.05 | gold quality |
| embryo | UBERON:0000922 | 89.04 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.04 | gold quality |
| right ovary | UBERON:0002118 | 88.98 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.95 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 88.92 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 88.78 | gold quality |
| cerebellar cortex | UBERON:0002129 | 88.68 | gold quality |
| mucosa of stomach | UBERON:0001199 | 88.66 | gold quality |
| metanephros cortex | UBERON:0010533 | 88.66 | gold quality |
| skin of abdomen | UBERON:0001416 | 88.55 | gold quality |
| right frontal lobe | UBERON:0002810 | 88.53 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124858 | no | 3.11 |
| E-ANND-3 | no | 2.22 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting ZNF414, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
Literature-anchored findings (GeneRIF, showing 1)
- KPNA7 binding and nuclear transfer was validated for two proteins, MVP and ZNF414. MVP and ZNF414 have a key role in the regulation of pancreatic cancer cell growth. (PMID:27664836)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf414 | ENSDARG00000079229 |
| mus_musculus | Zfp414 | ENSMUSG00000073423 |
| rattus_norvegicus | Zfp414 | ENSRNOG00000008378 |
Protein
Protein identifiers
Zinc finger protein 414 — Q96IQ9 (reviewed: Q96IQ9)
All UniProt accessions (5): Q96IQ9, M0R0Q5, M0R1G8, M0R2Q9, M0R398
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96IQ9-1 | 1 | yes |
| Q96IQ9-2 | 2 |
RefSeq proteins (2): NP_001139647, NP_115746 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR031799 | Znf-C2H2_ribbon | Domain |
| IPR039882 | ZN414 | Family |
Pfam: PF15909
UniProt features (15 total): compositionally biased region 5, zinc finger region 3, sequence variant 2, region of interest 2, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96IQ9-F1 | 60.86 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 76 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, SP1_Q2_01, EGR1_01, chr19p13, WHITFIELD_CELL_CYCLE_G1_S, EGR_Q6, MYC_UP.V1_DN, IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ALKBH3_TARGET_GENES, ARID5B_TARGET_GENES, BANP_TARGET_GENES, DYRK1A_TARGET_GENES, FOXN3_TARGET_GENES, GLI1_TARGET_GENES
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
570 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF414 | ACTMAP | Q5BKX5 | 446 |
| ZNF414 | CCDC97 | Q96F63 | 435 |
| ZNF414 | FAM124A | Q86V42 | 433 |
| ZNF414 | TSPAN13 | O95857 | 424 |
| ZNF414 | R3HCC1 | Q9Y3T6 | 421 |
| ZNF414 | ZNF32 | P17041 | 404 |
| ZNF414 | HDHD5 | Q9BXW7 | 397 |
| ZNF414 | SEC22A | Q96IW7 | 388 |
| ZNF414 | MED31 | Q9Y3C7 | 382 |
| ZNF414 | ZNF823 | P16415 | 370 |
| ZNF414 | TRABD | Q9H4I3 | 370 |
| ZNF414 | BEND6 | Q5SZJ8 | 367 |
| ZNF414 | GOLT1B | Q9Y3E0 | 357 |
| ZNF414 | FBXW2 | Q9UKT8 | 348 |
| ZNF414 | RNF14 | Q9UBS8 | 343 |
IntAct
180 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GOLGA2 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF414 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF414 | AHCYL1 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNF414 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTCH2NLC | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADAMTSL4 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM27 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRT34 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-3 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | TRIM10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | RBCK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | HOMER3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MKRN3 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PDE4DIP | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX11 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF414 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| KANK2 | ZNF414 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (153): ZNF414 (Two-hybrid), NPRL3 (Affinity Capture-MS), KDM4B (Affinity Capture-MS), EDRF1 (Affinity Capture-MS), PPP1R1A (Affinity Capture-MS), DEPDC5 (Affinity Capture-MS), NPRL2 (Affinity Capture-MS), HSD17B8 (Affinity Capture-MS), ANGEL1 (Affinity Capture-MS), ZNF414 (Two-hybrid), KDM4B (Affinity Capture-MS), KDM4A (Affinity Capture-MS), ZRANB1 (Affinity Capture-MS), ANKRD50 (Affinity Capture-MS), NOC4L (Affinity Capture-MS)
ESM2 similar proteins: A0A8I5KY20, A4IHR5, A7UKY7, A8IHN8, D3YYI7, G3V9M2, O43559, P39881, P49796, Q13387, Q14DQ1, Q2TAM9, Q32KV8, Q3UPL5, Q4VA45, Q5VUJ9, Q5VV17, Q5XKK7, Q62392, Q673H1, Q6NV74, Q6PJ61, Q6QHK4, Q6UXB0, Q7Z6J2, Q80TE3, Q86SH2, Q8BWU3, Q8CE64, Q8IWP9, Q8N554, Q8NFT6, Q8R4T5, Q8TC41, Q8VCC6, Q8WV24, Q96HA4, Q96IQ9, Q96SQ7, Q96T92
Diamond homologs: Q32KV8, Q5PPH4, Q96IQ9, Q9DCK4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 56 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 17 | 25.6× | 2e-18 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 5 | 26.6× | 3e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1125 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:8511021:TGCC:T | acceptor_gain | 1.0000 |
| 19:8511021:TGCCC:T | acceptor_loss | 1.0000 |
| 19:8511022:GCCCT:G | acceptor_loss | 1.0000 |
| 19:8511023:CC:C | acceptor_gain | 1.0000 |
| 19:8511024:CC:C | acceptor_gain | 1.0000 |
| 19:8511024:CCTG:C | acceptor_loss | 1.0000 |
| 19:8511025:C:CC | acceptor_gain | 1.0000 |
| 19:8511025:CTGC:C | acceptor_loss | 1.0000 |
| 19:8511026:T:C | acceptor_loss | 1.0000 |
| 19:8511481:CGCA:C | donor_loss | 1.0000 |
| 19:8511482:GCACC:G | donor_loss | 1.0000 |
| 19:8511483:CA:C | donor_loss | 1.0000 |
| 19:8511538:T:A | acceptor_loss | 1.0000 |
| 19:8511541:G:T | acceptor_gain | 1.0000 |
| 19:8511542:G:GC | acceptor_gain | 1.0000 |
| 19:8511612:CTCA:C | donor_loss | 1.0000 |
| 19:8511613:TCA:T | donor_loss | 1.0000 |
| 19:8511614:CA:C | donor_loss | 1.0000 |
| 19:8511615:AC:A | donor_gain | 1.0000 |
| 19:8511616:CC:C | donor_gain | 1.0000 |
| 19:8512385:A:AC | donor_gain | 1.0000 |
| 19:8512386:C:CC | donor_gain | 1.0000 |
| 19:8512502:A:C | acceptor_gain | 1.0000 |
| 19:8512600:CTAC:C | donor_loss | 1.0000 |
| 19:8512601:TA:T | donor_loss | 1.0000 |
| 19:8512602:ACC:A | donor_loss | 1.0000 |
| 19:8514043:CCAT:C | donor_gain | 1.0000 |
| 19:8511020:GTGCC:G | acceptor_gain | 0.9900 |
| 19:8511022:GCC:G | acceptor_gain | 0.9900 |
| 19:8511023:CCC:C | acceptor_gain | 0.9900 |
AlphaMissense
2481 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:8511937:A:G | F185S | 1.000 |
| 19:8511909:G:C | H194Q | 0.999 |
| 19:8511909:G:T | H194Q | 0.999 |
| 19:8511911:G:C | H194D | 0.999 |
| 19:8511911:G:T | H194N | 0.999 |
| 19:8511919:A:G | L191P | 0.999 |
| 19:8511936:G:C | F185L | 0.999 |
| 19:8511936:G:T | F185L | 0.999 |
| 19:8511938:A:G | F185L | 0.999 |
| 19:8511948:G:C | C181W | 0.999 |
| 19:8511950:A:G | C181R | 0.999 |
| 19:8511959:A:G | C178R | 0.999 |
| 19:8512389:G:C | F176L | 0.999 |
| 19:8512389:G:T | F176L | 0.999 |
| 19:8512390:A:G | F176S | 0.999 |
| 19:8512391:A:G | F176L | 0.999 |
| 19:8512432:A:G | L162P | 0.999 |
| 19:8512478:A:G | C147R | 0.999 |
| 19:8511907:A:G | L195P | 0.998 |
| 19:8511910:T:C | H194R | 0.998 |
| 19:8511912:C:A | K193N | 0.998 |
| 19:8511912:C:G | K193N | 0.998 |
| 19:8511916:A:G | F192S | 0.998 |
| 19:8511949:C:T | C181Y | 0.998 |
| 19:8511958:C:G | C178S | 0.998 |
| 19:8511959:A:T | C178S | 0.998 |
| 19:8512390:A:C | F176C | 0.998 |
| 19:8512404:T:A | K171N | 0.998 |
| 19:8512404:T:G | K171N | 0.998 |
| 19:8512461:G:C | C152W | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000887123 (19:8511029 G>A,T), RS1001164823 (19:8511997 C>T), RS1001887416 (19:8512260 C>A,T), RS1001918505 (19:8511983 G>A,C,T), RS1002900278 (19:8513268 T>A), RS1002923276 (19:8513120 G>A), RS1003729261 (19:8515659 C>T), RS1003886242 (19:8513874 G>A,T), RS1003938079 (19:8514175 T>C,G), RS1004095254 (19:8509215 T>C), RS1004709656 (19:8509975 G>A), RS1004939008 (19:8515487 C>G), RS1005062884 (19:8510535 G>A,C,T), RS1005503801 (19:8510172 C>A,T), RS1005828824 (19:8512311 G>A,C)
Disease associations
OMIM: gene MIM:620980 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects expression, increases abundance, increases expression | 2 |
| Arsenic | increases methylation, affects methylation | 2 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| kojic acid | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| pentanal | decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arbutin | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW43 | HEK293 eGFP-ZNF414 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.